ロード中...

Use of the Trypanosoma cruzi Recombinant Complement Regulatory Protein To Evaluate Therapeutic Efficacy following Treatment of Chronic Chagasic Patients

One of the greatest concerns in Chagas' disease is the absence of reliable methods for the evaluation of chemotherapy efficacy in treated patients. The tests available to evaluate cure after the specific treatment are the complement-mediated lysis (CoML) and flow cytometry tests, but they are n...

詳細記述

保存先:
書誌詳細
主要な著者: Meira, Wendell S. F., Galvão, Lúcia M. C., Gontijo, Eliane D., Machado-Coelho, George L. L., Norris, Karen A., Chiari, Egler
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2004
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC344465/
https://ncbi.nlm.nih.gov/pubmed/14766840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.42.2.707-712.2004
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!